Paraneoplastic Syndrome 2005-1

ED Vivas

ED Vivas Β· 2005

Influenza 2005-1

InfluenzaED Vivas

ED Vivas Β· 2005

Pneumonia, Legionella 2005-1

Pulmonary infectionsED Vivas

ED Vivas Β· 2005

TB, Secondary 2005-1

Pulmonary infectionsED Vivas

ED Vivas Β· 2005

Cirrhosis 2005-1

Hepatic failureED Vivas

ED Vivas Β· 2005

Pancreatitis, Acute 2005-1

ED Vivas

ED Vivas Β· 2005

Portal Hypertension 2005-1

Hepatic failureED Vivas

ED Vivas Β· 2005

Fracture Healing 2005-1

ED Vivas

ED Vivas Β· 2005

Variations in Drug Response 2005-1

Dose-Response CurvesED Vivas

ED Vivas Β· 2005

Efficacy and Potency 2005-1

ED Vivas

ED Vivas Β· 2005

Bioavailability 2005-1

First pass metabolismED Vivas

ED Vivas Β· 2005

Nitric Oxide 2005-1

Nitric oxideED Vivas

ED Vivas Β· 2005

Lignocaine 2005-1

ED Vivas

ED Vivas Β· 2005

Betablockers 2005-1

PropranololED Vivas

ED Vivas Β· 2005

Clopidogrel 2005-1

ED Vivas

ED Vivas Β· 2005

Valproate 2005-1

ED Vivas

ED Vivas Β· 2005

Antipsychotics 2005-1

ED Vivas

ED Vivas Β· 2005

Penicillin 2005-1

ED Vivas

ED Vivas Β· 2005

Sulphonamides 2005-1

SulphonamidesED Vivas

ED Vivas Β· 2005

Antiemetics 2005-1

ED Vivas

ED Vivas Β· 2005